期刊文献+

甲状腺功能亢进患者PICP、ICTP和BGP等骨代谢指标水平的变化 被引量:11

Variation of bone metabolism index PICP,ICTP and BGP in patients with hyperthyrea
下载PDF
导出
摘要 目的测定甲状腺功能亢进(简称甲亢)患者骨代谢指标,探讨甲状腺激素与骨代谢的关系。方法 49例以甲亢患者为甲亢组,34例体检健康者为对照组,放射免疫法检测血清Ⅰ型前胶原羧基末端前肽(PICP)、Ⅰ型胶原羧基端吡啶并啉交联肽(ICTP)和骨钙素(BGP)、碱性磷酸酶(ALP)、总三碘甲腺原氨酸(TT3)、总甲状腺素(TT4)。结果甲亢组血清PICP、ICTP、BGP、ALP水平高于对照组(P<0.05),相关分析表明血清TT3、TT4与PICP、ICTP、BGP、ALT均呈正相关。结论甲状腺激素可直接参与骨代谢,甲亢患者骨吸收过程增加较为明显,造成骨量丢失。 Objective To investigate the relationship between thyroid hormone and bone metabolism in patients with hyperthyrea.Methods Serum procollagen ⅠC-terminal propeptider(PICP),carboxy-terminal cross linked telopeptide of type Ⅰcollagen(ICTP),bone gla protein(BGP),alkaline phosphatase(ALP),total 3,5,3′-triiodothyronine(TT3)and total tetraiodothyronine(TT4)were detected in 49 patients with hyperthyrea and also 34 healthy controls.Results Serum levels of PICP,ICTP,BGP and ALP in patients group were higher than those in control group(P〈0.05),and there were positive correlation between serum levels of TT3,TT4 and PICP,ICTP,BGP and ALP.Conclusion Thyroid hormone possible participate bone metabolism directly,and the bone formation mass might be lost as the bone absorption process obviously increase in patients with hyperthyrea
出处 《国际检验医学杂志》 CAS 2011年第12期1306-1307,共2页 International Journal of Laboratory Medicine
关键词 甲状腺功能亢进症 骨钙素 碱性磷酸酶 Ⅰ型前胶原羧基末端前肽 Ⅰ型胶原羧基端吡啶并啉交联肽 hyperthyrodism osteocalcin alkaline phosphatase carboxy terminal propeptide of type Ⅰ proeollagen cross-linked carboxy-terminal telopeptide of type I collagen
  • 相关文献

参考文献12

二级参考文献29

  • 1蔡桂英,葛雪琳,魏玲,杨霞,杨秀川,王莉,李金祥.血清骨钙素水平的观察[J].中国骨质疏松杂志,1999,5(2):29-32. 被引量:19
  • 2潘时中,严孙杰,王敏,赵淑好,张松菁,陈洪基.Graves病患者骨密度与骨代谢变化的研究[J].中华内分泌代谢杂志,1995,11(2):119-119. 被引量:7
  • 3郑兵.甲状腺功能检测指标临床意义[J].实用医技杂志,2006,13(4):547-548. 被引量:20
  • 4李景学.骨矿物质影像学研究的新趋向[J].中华放射学杂志,1996,30(1):56-58. 被引量:17
  • 5张秀明,李炜煊,郑松柏,陈滨鸿,曹永坚,孙蕾,林莲英,柯培锋,马骥.不同检测系统17项常规生化结果的比对和偏倚评估[J].检验医学,2007,22(2):166-170. 被引量:47
  • 6National Committee for Clinical Laboratory Standards. Method comparison and bias estimation using patient samples[S]. Approved Guideline, 2nd ed, EP9-A2, 2002.
  • 7Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T (4),and thyroid antibodies in the United States population(1988 to 1994): National Health and d Nutrition Examination Survey (NHANES m). J Clin Endocrinol Metab, 2002,87 : 489-499.
  • 8Vandewump MPJ, Tunbridge WMG, French JM, et al. The incidence of thyroid disorders in the community:a twenty year follow up of the Whickham survey. Clin Endocrinol(Oxf), 1995, 43:55 -68.
  • 9Chiovato I, Fiore E, Vitti P, et al. Outcome of thyroid functionin Graves patient with radioiodine:role of thyroidstimulatingand thy rotropin blocking antibodies and radioiodine induced thyroid damage[J].J Clin Endocrinol Meted,1998,83(1):40.
  • 10Caldwell Y, Hiyama Y, Shimojo N, et al. Autoantibodies to thyroidperoxidase in patientswith chronic thyroiditis: effect of antibody binding on enzyme activities. Clin Exp Immunol, 1985,65 : 534.

共引文献87

同被引文献77

引证文献11

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部